Evidence map›Paper›PMID 34373590›Full record

ArticleBone marrow transplantation2021

Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.

U Thiel, S J Schober, A Ranft, H Gassmann, S Jabar, K Gall, I von Lüttichau, A Wawer, E Koscielniak, M A Diaz and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

U Thiel *Department of Pediatrics and Children's Cancer Research Center, School of Medicine, Kinderklinik München Schwabing, Technical University of Munich, Munich, Germany. uwe.thiel@tum.de.ORCID http://orcid.org/0000-0002-3574-7337
S J Schober *Department of Pediatrics and Children's Cancer Research Center, School of Medicine, Kinderklinik München Schwabing, Technical University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-5650-4035
A RanftPediatrics III, West German Cancer Centre Essen, University Hospital Essen, Essen, Germany.
H GassmannDepartment of Pediatrics and Children's Cancer Research Center, School of Medicine, Kinderklinik München Schwabing, Technical University of Munich, Munich, Germany.
S JabarPediatrics III, West German Cancer Centre Essen, University Hospital Essen, Essen, Germany.
K GallDepartment of Pediatrics and Children's Cancer Research Center, School of Medicine, Kinderklinik München Schwabing, Technical University of Munich, Munich, Germany.
I von LüttichauDepartment of Pediatrics and Children's Cancer Research Center, School of Medicine, Kinderklinik München Schwabing, Technical University of Munich, Munich, Germany.
A WawerDepartment of Pediatrics and Children's Cancer Research Center, School of Medicine, Kinderklinik München Schwabing, Technical University of Munich, Munich, Germany.
E KoscielniakDepartment of Pediatric Oncology, Hematology and Immunology, Olgahospital, Stuttgart, Germany.
M A DiazDepartment of Pediatric Hematology-Oncology and Hematopoietic Stem Cell Transplantation, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
M UssowiczDepartment of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.ORCID http://orcid.org/0000-0001-5725-4835
I KazantsevRaisa Gorbacheva Memorial Institute for Pediatric Oncology, Hematology and Transplantat, Pavlov First St. Petersburg State Universityion, St. Petersburg, Russia.ORCID http://orcid.org/0000-0002-3818-6213
B AfanasyevRaisa Gorbacheva Memorial Institute for Pediatric Oncology, Hematology and Transplantat, Pavlov First St. Petersburg State Universityion, St. Petersburg, Russia.
M MerkerDepartment of Pediatric Hematology and Oncology, Universitätsklinikum Frankfurt, Frankfurt, Germany.
T KlingebielDepartment of Pediatric Hematology and Oncology, Universitätsklinikum Frankfurt, Frankfurt, Germany.ORCID http://orcid.org/0000-0001-5726-9092
A PreteDepartment of Pediatric Hematology and Oncology, Ospedale S Orsola Malpighi, Bologna, Italy.
B GruhnDepartment of Pediatrics, Jena University Hospital, Jena, Germany.ORCID http://orcid.org/0000-0003-1862-0075
P BaderDepartment of Pediatric Hematology and Oncology, Universitätsklinikum Frankfurt, Frankfurt, Germany.
H JürgensDepartment of Pediatric Hematology and Oncology, Universitätsklinikum Münster, Münster, Germany.
U DirksenPediatrics III, West German Cancer Centre Essen, University Hospital Essen, Essen, Germany.ORCID http://orcid.org/0000-0002-5435-7860
R HandgretingerDepartment of Pediatric Hematology and Oncology, Universitätsklinikum Tübingen, Tübingen, Germany.
S BurdachDepartment of Pediatrics and Children's Cancer Research Center, School of Medicine, Kinderklinik München Schwabing, Technical University of Munich, Munich, Germany.
P LangDepartment of Pediatric Hematology and Oncology, Universitätsklinikum Tübingen, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34373590
PMCPMC8410592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.